Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Submitted by
admin
on November 1, 2017 - 10:02am
Source:
Drug Delivery Business News
News Tags:
Novo Nordisk
earnings
diabetes
insulin
drug pricing
Headline:
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Do Not Allow Advertisers to Use My Personal information
